ARTICLE | Clinical News
Lucentis ranibizumab regulatory update
March 3, 2014 8:00 AM UTC
Novartis said Japan approved Lucentis ranibizumab to treat diabetic macular edema (DME). Lucentis is approved in Japan to treat wet age-related macular degeneration (AMD), visual impairment due to mac...